About the Company
We do not have any company description for Voyager Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Voyager Therapeutics, Inc.
Voyager Reports Second Quarter 2025 Financial and Operating Results
Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs - - APOE program added to pipeline; fourth asset in industry-leading Alzheimer’s disease franchise - - 11 ...
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing ...
LEXINGTON, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment ...
Voyager Therapeutics to Present at the Chardan Genetic Medicines ...
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today ...
Voyager Therapeutics Extends Cash Runway to 2028
Voyager Therapeutics Inc. ( (VYGR) ) has released its Q2 earnings. Here is a breakdown of the information Voyager Therapeutics Inc. presented to its investors.Elevate Your Investing Strategy: Take ...
Voyager Therapeutics’ Novel Capsids Demonstrate Robust Delivery ...
--Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for serious neurological diseases, today will present new preclinical data ...
VYGR | Voyager Therapeutics Inc. Profile | MarketWatch
Voyager Therapeutics Inc. 75 Hayden Avenue Lexington, Massachusetts 02421 Phone1 857 259-5340 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2024 Revenue$250.01M Net IncomeN/A ...
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
LEXINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the ...
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and ...
LEXINGTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will ...
Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of ...
Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors Dec. 14, 2022 7:00 AM ET CareDx, Inc (CDNA), VYGR ...
Voyager Therapeutics Appoints Catherine J. Mackey, Ph.D. to ... - Nasdaq
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation adeno-associated virus ...
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing ...
Voyager Therapeutics, Inc. is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases.
Similar Companies
Loading the latest forecasts...